In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at

Zaid Alsaaran1, Michael D Hill2,

  • 1Cumming School of Medicine, University of Calgary, and King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Calgary, Alberta, Canada, and Riyadh, Saudi Arabia (Z.A.).

Abstract

Related Concept Videos